We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Control Bionics is a medical devices business based in Australia. Control Bionics shares (CBL) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Control Bionics has a trailing 12-month revenue of around $4.2 million. If you're looking to buy shares, check out the steps below.
Our top pick for
US stocks
Our top pick for
Overall broker
Our top pick for
Low-cost broker
| 52-week range | $0.115 - $0.745 |
|---|---|
| 50-day moving average | $0.2558 |
| 200-day moving average | $0.4075 |
| Target price | $1.32 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.067 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$0.2
| 1 week (2022-06-24) | 42.86% |
|---|---|
| 1 month (2022-06-02) | -18.37% |
| 3 months (2022-04-01) | -41.18% |
| 6 months (2021-12-31) | -52.94% |
| 1 year (2021-07-02) | -70.15% |
|---|
| Revenue TTM | $4.2 million |
|---|---|
| Gross profit TTM | $2.7 million |
| Return on assets TTM | -15.94% |
| Return on equity TTM | -31.03% |
| Profit margin | -133.49% |
| Book value | 0.171 |
| Market capitalisation | $13 million |
TTM: trailing 12 months
We're not expecting Control Bionics to pay a dividend over the next 12 months.
Control Bionics Limited engages in the research, development, commercialization, and sale of assistive communications technology systems that allows user with speech and movement disabilities in Australia and North America. It offers NeuroNode Trilogy, a wearable device solution for those living with paralysis and loss of speech; NeuroNode3, a wearable EMG control device; and Control Bionics CCS that allow users to communicate with friends and family, send and receive emails and text messages, browse the web, watch videos and movies, read the news, play games, control their home environmental control systems, and others. The company was formerly known as Control Bionics Holdings Pty Limited and changed its name to Control Bionics Limited in September 2020. Control Bionics Limited was incorporated in 2005 and is based in Camberwell, Australia.
Steps to owning and managing Kincora Copper shares.
Everything we know about the Dragon Mountain Gold IPO, plus information on how to buy in.
Steps to owning and managing Arcadia Minerals shares.
Steps to owning and managing Nexgen Energy shares.
Steps to owning and managing Keypath Education shares.
If you want to directly fund climate solutions a green bond is a great place to start. Here is how they work.
What's the best way to invest money in Australia? Find out about robo advisors, index funds, cryptocurrency and more in this guide.
Steps to owning and managing EBR Systems shares.
Steps to owning and managing 5E Advanced Materials shares.
Steps to owning and managing Leo lithium shares.
